摘要
采用药物利用评价法(DUR)和药物利用评估法(DUE)相结合,对冠心病120例患者的临床用药情况进行评价与分析。主要治疗用药29种,7种药物DUI<1,18种药物DUI=1,4种药物DUI>1。使用频度占前3位的药物分别为阿司匹林肠溶片、缬沙坦胶囊、硫酸氢氯吡格雷片。在DUE评价中,对于用药前心电图、肝肾功能等检查率为100%,但是对于用药后异常指标再监测,各指标各异。以DUI和DUE为评价程序,可以从药物的治疗前、治疗过程监测和治疗效果评价等来综合评价用药合理性。
Combining drug utilization review and drug utilization evaluation, 120 patients with coronary heart disease （ CHD） were assessed. Among the 29 kinds of drugs involved, the values of drug utilization index （ DUI） were under 1 for 7 kinds, equal to 1 for 18 kinds and over 1 for 4 kinds. The top three drugs in the rank of usage frequency were aspirin enteric-coated tablets, valsartan capsules and clopidogrel hydrogen sulphate tablets. The combination of drug utilization review with drug utilization evaluation could be a more comprehensive evaluation of drug utilization.
出处
《药学与临床研究》
2017年第2期163-166,178,共5页
Pharmaceutical and Clinical Research
关键词
药物利用评价
药物利用评估
冠心病
Drug utilization review
Drug utilization evaluation
CHD
